Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccinal effect of HIV-1 antibody therapy
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 325-333
Open Access | Times Cited: 18

Showing 18 citing articles:

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization
Bin Su, Stefania Dispinseri, Valeria Iannone, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 54
Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions
Philippe Van de Perre, Ameena Goga, Nobubelo Ngandu, et al.
The Lancet (2021) Vol. 397, Iss. 10281, pp. 1316-1324
Open Access | Times Cited: 35
Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells
Jérémy Dufloo, Cyril Planchais, Stéphane Frémont, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity
Romila Moirangthem, Sapir Cordela, Dina Khateeb, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3712-3728
Open Access | Times Cited: 2
Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
Chad J. Roy, Greta Van Slyke, Dylan Ehrbar, et al.
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 16
An exploration of how broadly neutralizing antibodies might induce HIV remission: the ‘vaccinal’ effect
Timothy Tipoe, Sarah Fidler, John Frater
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 3, pp. 162-170
Closed Access | Times Cited: 10
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 1
Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection
Aubin Pitiot, Marion Ferreira, Christelle Parent, et al.
Mucosal Immunology (2023) Vol. 16, Iss. 3, pp. 312-325
Open Access | Times Cited: 4
Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy
Mar Naranjo‐Gómez, Marine Cahen, Jennifer Lambour, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 137-137
Open Access | Times Cited: 9
Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques
Widade Ziani, Anya M. Bauer, Hong Lü, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 8
Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption
Xiaolei Wang, Huanbin Xu
Viruses (2021) Vol. 13, Iss. 2, pp. 335-335
Open Access | Times Cited: 7
IgA antibodies against HIV-1
Valérie Lorin, Hugo Mouquet
Virologie (2024) Vol. 00, Iss. 00, pp. 00-00
Open Access
Trade-off between the antiviral and vaccinal effects of antibody therapy in the humoral response to HIV
Soumya Mittal, Amar K. Garg, Rajat Desikan, et al.
Journal of The Royal Society Interface (2024) Vol. 21, Iss. 221
Closed Access
Differential and sequential immunomodulatory role of neutrophils and Ly6Chi inflammatory monocytes during antiviral antibody therapy
Jennifer Lambour, Mar Naranjo‐Gómez, Myriam Boyer-Clavel, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 964-981
Open Access | Times Cited: 4
Dual neutralization of influenza virus hemagglutinin and neuraminidase by a bispecific antibody leads to improved antiviral activity
Romila Moirangthem, Sapir Cordela, Dina Khateeb, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Editorial: Advances in T Cell Therapeutic Vaccines for HIV
Bernard Macatangay, Alan Landay, Felipe García, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 2
Differential and sequential immunomodulatory role of neutrophils and Ly6Chiinflammatory monocytes during antiviral antibody therapy
Jennifer Lambour, Mar Naranjo‐Gómez, Myriam Boyer-Clavel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Mucosal administration of anti-bacterial antibody provides long-term cross-protection against Pseudomonas aeruginosa respiratory infection
Aubin Pitiot, Marion Ferreira, Christelle Parent, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top